PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
27.06%
Positive revenue growth while CX is negative. John Neff might see a notable competitive edge here.
316.29%
Gross profit growth above 1.5x CX's 1.03%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1708.06%
EBIT growth above 1.5x CX's 2.60%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1708.06%
Operating income growth above 1.5x CX's 2.60%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
132.28%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
105.26%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
105.26%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
11.99%
Share count expansion well above CX's 3.68%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
12.42%
Diluted share count expanding well above CX's 3.68%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
328.66%
Positive 10Y revenue/share CAGR while CX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
2115.31%
5Y revenue/share CAGR above 1.5x CX's 103.54%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.07%
3Y revenue/share CAGR at 50-75% of CX's 79.82%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
459.71%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
91.12%
5Y net income/share CAGR 1.25-1.5x CX's 69.99%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
58.88%
Below 50% of CX's 2840.61%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.